Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate
US12350344B2 · kind B2 · utility
0Cited by
3References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2022 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Oct 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.